Wells Fargo
CLYM

Wells Fargo’s Climb Bio CLYM Stock Holding History

Wells Fargo’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$400K Buy
+30,660
New +$317K ﹤0.01% 4780
2025
Q3 		– Sell
-244
Closed -$303 – 7473
2025
Q2 		$303 Sell
244
-17,205
-99% -$21.4K ﹤0.01% 6419
2025
Q1 		$21.3K Buy
17,449
+387
+2% +$628 ﹤0.01% 5690
2024
Q4 		$30.7K Buy
17,062
+3,814
+29% +$13.8K ﹤0.01% 5632
2024
Q3 		$67.4K Buy
13,248
+10,099
+321% +$71.4K ﹤0.01% 5229
2024
Q2 		$22.4K Buy
3,149
+3,099
+6,198% +$20.6K ﹤0.01% 5550
2024
Q1 		$137 Buy
50
+2
+4% +$6 ﹤0.01% 6586
2023
Q4 		$130 Buy
48
+3
+7% +$8 ﹤0.01% 6705
2023
Q3 		$118 Hold
45
– – ﹤0.01% 6726
2023
Q2 		$126 Buy
45
+3
+7% +$9 ﹤0.01% 6821
2023
Q1 		$122 Hold
42
– – ﹤0.01% 6894
2022
Q4 		$154 Buy
42
+1
+2% +$3 ﹤0.01% 6696
2022
Q3 		$0 Sell
41
-3
-7% -$10 ﹤0.01% 7528
2022
Q2 		$0 Sell
44
-3,674
-99% -$17.4K ﹤0.01% 7651
2022
Q1 		$31K Sell
3,718
-2,706
-42% -$25.2K ﹤0.01% 5857
2021
Q4 		$67K Buy
6,424
+6,393
+20,623% +$95.3K ﹤0.01% 5833
2021
Q3 		$1K Buy
+31
New +$640 ﹤0.01% 6819

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wells Fargo's CLYM Position: Q2 2026 in Review

Wells Fargo opened a new position in Climb Bio (CLYM) in Q2 2026: 30,660 shares worth $400K. The stake represents ﹤0.01% of the portfolio and ranks #4780 among its holdings. This is a return to the name: Wells Fargo previously reported a position in CLYM as recently as Q2 2025.

Wells Fargo first reported a position in CLYM in Q3 2021 and has held it in 17 quarters since. 109 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Wells Fargo held 30,660 shares of Climb Bio worth $400K as of Q2 2026.
  • Climb Bio was a new Wells Fargo position in Q2 2026.
  • Climb Bio made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4780 holding.
  • Wells Fargo first reported a position in Climb Bio in Q3 2021 and has held it in 17 quarters since.
  • 109 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.